Sercan Aksoy

27PUBLICATIONS
191CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsClinical midwiferyPredictive and prognostic markersNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 28, 2026
Guideline adherence in the management of aromatase inhibitor-induced bone loss in women with breast cancer.

|Jul 28, 2026
Comparison of Neoadjuvant TCHP and ddAC+THP Regimens for Pathologic Complete Response in HER2-Positive Breast Cancer: A Multicenter Real-World Analysis of Systemic Inflammatory Biomarkers.

|Jun 25, 2026
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|Mar 16, 2026
Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study.

Taha Koray Sahin, Fatih Kemik, Harun Muglu

|Feb 27, 2026
Prognostic Value of Baseline Sarcopenia and Adipose Tissue Indices in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors: A Retrospective Cohort Study.

Latif Karahan, Arif Akyildiz, Taha Koray Sahin

|Jun 27, 2025
Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel.

Hakan Taban, Mustafa Erman, Deniz Can Guven

Pageof 5

Frequent Collaborators

12 joint publications

Deniz Can Guven

8 joint publications

Taha Koray Sahin

4 joint publications

Ozgur Sahin

3 joint publications

Mehmet Ruhi Onur